The Big Impact Of Medable AI

Medable AI, the newest upgrade to Medable Studio, streamlines clinical trial study creation by automating and accelerating the eCOA build process. Leveraging secure, pre-trained Generative AI models, it can instantly convert paper-based assessments into digital formats and perform repetitive configurations—such as building multiple scale screens—through simple chat prompts. This eliminates the slow, linear workflows of traditional methods, reducing back-and-forth between sponsors, vendors, and authors and significantly shortening build times.

Unlike competitors reliant on manual, repetitive tasks, Medable AI delivers scalable, adaptable solutions that keep eCOA off the critical path to first patient in (FPI). All outputs remain under human review and approval to ensure quality, while no patient data is accessed. By combining operational efficiency with cutting-edge AI, Medable AI enables faster, more flexible trial execution, positioning itself as the first industry solution to embed Generative AI into study builds—helping sponsors and CROs bring life-saving treatments to market sooner.